Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

Introduction The increasing incidence of type 2 diabetes mellitus (T2DM) among women of reproductive age poses significant health risks for both mothers and their fetuses. Optimising blood glucose ...

TAMPA, Fla., Jan. 20, 2026 /PRNewswire/ -- PainTEQ, a leader in minimally invasive solutions for sacroiliac (SI) joint dysfunction, today announced a significant investment in its clinical and ...

Levee Medical(R) , a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced continued progress in the clinical and commercial advancement of its ...

Concept Medical has enrolled the first patients in the STARS DAPT global trial evaluating its polymer-free Abl ...

SpyGlass Pharma, a late-stage biopharmaceutical company, today announced that the first patients have been randomized in two registrational Phase III clinical trials of its lead product candidate, the ...

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) said it has launched a placebo-controlled Phase 1b proof-of-concept ...

Background Foodborne diseases are an important cause of global morbidity and mortality, particularly among children who often ...

Levee Medical®, a medical device company focused on improving outcomes for prostate cancer surgery patients, today announced continued progress in the clinical and commercial advancement of its Voro® ...

撰文丨王聪编辑丨王多鱼排版丨水成文随着人口老龄化和慢性病负担加重，全球医疗系统正面临前所未有的压力。在资源有限的地区，患者往往需要经历漫长的等待和碎片化的护理流程。例如，在中国，许多患者习惯于绕过初级护理直接前往大医院，导致专科医生负担过重，咨询时间 ...

The NCCN guidelines now include MammaPrint for identifying HR+/HER2- early-stage breast cancer patients who may benefit from ...

SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...